Pharmacists likely to play direct role in future diabetes management

December 18, 2006

Community pharmacists could soon be playing a more direct role in diabetes management following a new study at Brisbane's Wesley Research Institute funded by the MBF Foundation.

The aim of the study is to help people with Type 2 Diabetes gain better control over their blood glucose levels to reduce their need for visits to the doctor or hospital admissions.

Wesley Research Institute Director, Professor Julie Campbell, said that patients in the study would use hi-tech glucose meters to measure their blood glucose levels at varying times during the day. The metres are attached to their computers and a special software program is used to chart changes in glucose levels.

"Half the study participants will take this information to their pharmacists who can advise on lifestyle changes to help moderate their blood glucose levels and prevent them becoming unwell," said Professor Campbell. "The other half will continue to manage their blood glucose levels themselves."

It is hoped that the year long study to be completed at the end of 2007 will lead to new Australia-wide treatment standards for Type 2 Diabetes where patients and pharmacists work together to manage the disease.

MBF Chief Medical Officer, Dr Christine Bennett, said MBF Foundation is supporting this innovative study to enable Australians facing the challenges of diabetes to take greater control of their condition and improve their overall health and life enjoyment.

The MBF Foundation is a charitable institution set up by MBF to support and manage important health initiatives for the community using a portion of MBF Group's investment income each year. Projects undertaken encompass three key areas - wellness and obesity, supporting healthy ageing and keeping healthcare affordable.
-end-


Research Australia

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.